Introduction
Due to the limited regenerative capacity of cardiomyocytes, the healing of cardiac tissue after a myocardial infarction (MI) is inadequate compared with healing processes after tissue damage in organs such as the liver. Inadequate healing after MI can lead to heart failure (HF) and ventricular rupture, an extreme and often fatal condition. 1, 2 The molecular players modulating wound healing are gradually being identified. However, therapies that ensure optimal healing of injured cardiac tissue have yet to be established, suggesting that a more comprehensive understanding of post-MI wound healing is urgently needed to develop effective targeted therapies. Wound healing after MI results from a superbly orchestrated series of events, beginning with immune responses to clear the wound of dead cells and matrix debris and followed by activation of the tissue repair programme. [3] [4] [5] The early inflammation is a required event for the transition to the later stages of proliferation and tissue repair. 3, 4 However, an inflammatory phase that is excessive in magnitude, prolonged, or insufficiently suppressed can lead to sustained myocardial damage and defective healing, thereby promoting infarct expansion, cardiac dysfunction, and lethal cardiac rupture. 3, 4, 6 Therefore, timely containment and resolution of inflammation is necessary for optimal post-MI repair of cardiac tissue. Nuclear factor-jB (NFjB) plays a critical role in the post-MI inflammatory response. In infarcted hearts, danger-associated molecular patterns released by dying cardiomyocytes and degraded extracellular matrix (ECM) components are recognized by Toll-like receptors (TLRs) and other pattern recognition receptors on surviving cells, which leads to NFjB activation. Activated NFjB in turn up-regulates the expression of a large panel of proinflammatory mediators including inflammatory cytokines, chemokines, and cell adhesion molecules. Chemokines are inflammatory mediators with an essential role in leucocyte trafficking, and some chemokines such as interferon-c-inducible protein 10 (IP-10), also exert anti-fibrotic and anti-angiogenic effects. 4, [7] [8] [9] Thus, inhibiting NFjB inflammatory signalling serves as a promising therapeutic strategy for post-MI wound healing. 10, 11 Heat shock protein B1 (HSPB1), which is also called HSP25 in rodents and HSP27 in primates, encodes a member of the small heat shock protein family. A range of stimuli including oxidative stress, cytokines, and growth factors, can induce HSPB1 expression to acquire tolerance. 12 We and others have demonstrated that HSPB1 attenuates doxorubicininduced cardiac dysfunction, alleviates cardiac aging, and delays cardiac allograft rejection. [13] [14] [15] Recent studies using the Langendorff-perfused heart model demonstrated that non-selective overexpression of HSPB1 improves cardiac contractility within 1 h of reperfusion after 20-35 min of ischaemia. 16, 17 However, it is unknown whether HSPB1 specifically within cardiomyocytes can modulate wound healing after MI. Given that HSPB1 in cardiomyocytes attenuated endotoxin-induced cardiac dysfunction and NFjB activation in our previous study, 18 it is possible that HSPB1 in cardiomyocytes plays a role in infarct healing after MI.
To test this hypothesis, we generated cardiomyocyte-specific HSPB1 knockout mice (Hspb1 À/À ). HSPB1 expression was up-regulated in wildtype (WT) cardiomyocytes in response to MI, while deficiency of cardiomyocyte HSPB1 impaired infarct healing, as indicated by aggravated remodelling, worse cardiac dysfunction, and increased risk of cardiac rupture. These actions of cardiomyocyte HSPB1 were due, at least in part, to the NFjB-dependent modulation of leucocyte recruitment and the subsequent inflammation. These data suggest that HSPB1 acts as a negative regulator of inflammatory responses in cardiomyocytes and plays an essential role in the healing of injured cardiac tissue after MI.
Methods
Additional materials and methods are available in Supplementary material online.
Generating cardiomyocyte-specific HSPB1 knockout mice (Hspb1
HSPB1 conditional knockout mice were generated using loxP recombinant system (details shown in Supplementary material online). Knockout of HSPB1 selectively in cardiomyocytes was achieved by cross-breeding HSPB1 conditional knockout mice with aMHC-Cre transgenic mice. Mice were housed in the Model Animal Research Center of Nanjing University and maintained in the Animal Laboratory Resource Facility at Nanjing University. All the experiments were conducted under the guidelines for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication, 8th Edition, 2011).
The animal care and experimental protocols were approved by the Nanjing University Committee on Animal Care. All the experiments were conformed to the international guidelines on the ethical use of animals.
Surgical procedures
MI was induced in 8-12-week-old WT and Hspb1 À/À mice by permanently ligating the left anterior descending coronary (LAD) as described in our previous studies. 19 All the experiments used male mice unless indicated elsewhere. Mice were anaesthetized by sodium pentobarbital (50 mg/kg, intraperitoneal injection). The adequacy of anaesthesia was assayed by the disappearance of righting reflex and pedal withdrawal reflex. After anaesthesia, mice were subjected to mechanical ventilation, chest opening along the left sternal border, and permanent LAD ligation.
In sham-operated animals, the same procedure was performed except the LAD occlusion. For analgesia, buprenorphine (0.05 mg/kg) was administrated subcutaneously prior to surgery, and administrated one dose every 8 h for the next 48 h. For tissue collection, mice were sacrificed by overdose anaesthesia (pentobarbital sodium 150 mg/kg intraperitoneal injection) and cervical dislocation. In NFjB inhibition experiments, mice were administrated with pyrrolidinedithiocarbamate (PDTC, 100 mg/kg) intraperitoneally 30 min prior to surgery followed by 100 mg/kg/day for first three days after surgery. 15 
Mice survival and cardiac rupture
Mice survival was checked twicely per day after surgery. All dead mice received autopsy to dissect the cause of death. The presence of perforation on the infarcted wall, which was accompanied by an intrathoracic blood clot was diagnosed as cardiac rupture. 
Infarct size
Infarct size was determined by triphenyltetrazolium chloride (TTC) staining and expressed as the percentage of infarct over ventricular areas, as previously described. 19 
Echocardiography
Echocardiography was used to evaluate cardiac function and remodelling at the indicated times post-MI using the Vevo770 system equipped with a 35-MHz transducer (Visualsonics, Toronto, Canada) according to our previous methods. 19 The measurements were performed by an observer blinded to the treatment. Parameters were obtained from M-mode tracings and averaged using three to five cardiac cycles.
Real-time PCR
Real-time PCR was used to analyse mRNA expression levels according to our previous studies. 20 The expression of genes of interest was expressed as a relative expression compared with that of WT controls. The primers were listed in Supplementary material online, Table S1 .
Western blot
Western blot was performed as described in our previous studies. 19, 21 The expression of genes of interest was expressed as a relative expression compared with that of WT controls.
Statistical analysis
Data are presented as mean ± standard deviation. Comparisons between groups were performed by Student's two-tailed unpaired t-test, one-way or two-way analysis of variance analysis followed by Tukey post hoc test. Survival curve was analysed by log-rank test. Statistical significance was set at P < 0.05.
Results

HSPB1 expression is up-regulated in cardiomyocytes in response to MI
To investigate the possible involvement of HSPB1 in myocardial healing post-MI, we first examined whether cardiac HSPB1 expression is affected by MI. A significant up-regulation of HSPB1 was observed in the myocardium at both the mRNA (11.3 ± 6.4 vs. 1 .0 ± 0.3, P < 0.01) and protein levels (2.3 ± 0.5 vs. 1.0 ± 0.2, P < 0.01) at 24 h after MI, compared with the sham controls ( Figure 1A and B). HSPB1 remained up-regulated at 7 days post-MI (4.2 ± 1.9 vs. 1.0 ± 0.2, P < 0.01), and HSPB1 expression was most evident in the cardiomyocytes of the infarct border ( Figure 1B and C). Notably, in vitro experiments showed an increase in Hspb1 mRNA in primary cardiomyocytes exposed to simulated ischaemia by deprivation of glucose and oxygen (referred to as hypoxia hereafter; 1.8 ± 0.6 vs. 1.0 ± 0.2, P < 0.05, Figure 1A ). Together, these findings indicate an up-regulation of HSPB1 in cardiomyocytes in response to MI.
Generation of cardiomyocyte-specific HSPB1 knockout (Hspb1
The up-regulation of HSPB1 in cardiomyocytes after MI prompted us to investigate its functional requirement during post-infarct healing. We, therefore, generated cardiomyocyte-specific HSPB1 knockout (Hspb1 À/À ) mice. The strategy for generating Hspb1 À/À mice is shown in Figure 2A and Supplementary material online, Figure S1A . The specific knockout of HSPB1 in cardiomyocytes was verified by the absence of HSPB1 protein in the myocardium and in isolated adult cardiomyocytes from Hspb1 À/À mice ( Figure 2B 
Cardiomyocyte-specific deficiency of HSPB1 enlarges infarct size
The infarct sizes were 40.4% ± 2.5% and 56.1% ± 3.7% in WT and Hspb1 À/À mice, respectively, 24 h after MI ( Figure 3A) . Therefore, the infarcts in Hspb1 À/À mice were 38.9% larger than in WT mice (P < 0.01).
The areas at ischaemic risk were comparable between the two groups (see Supplementary material online, Figure S2 ).
3.5
Cardiomyocyte-specific deficiency of HSPB1 worsens cardiac dysfunction and promotes adverse remodelling after MI Cardiac function and remodelling were examined serially on days 1, 3, and 7 after MI by echocardiography ( Figure 3B ). Sham mice served as basal controls, and no differences were observed between the two genotypes. However, after MI, Hspb1 À/À mice showed significantly worse cardiac function, as indicated by decreases in the ejection fraction (EF), fractional shortening (FS), and stroke volume, compared with timematched WT controls (P < 0.01 or 0.05).
Cardiac remodelling is reflected by changes in the left ventricular (LV) diameter and wall thickness (Figure 3B). Hspb1
À/À mice exhibited promoted adverse remodelling, as shown by LV enlargement (increases in LV internal diameter at diastolic phase, LV internal diameter at systolic phase, LV end-diastolic volume, and LV end-systolic volume) and wall thinning (decreases in interventricular septal thickness at diastolic phase, interventricular septal thickness at systolic phase, LV posterior wall thickness at diastolic phase and LV posterior wall thickness at systolic phase) compared with the time-matched WT controls (P < 0.01 or 0.05).
3.6
Cardiomyocyte-specific deficiency of HSPB1 suppresses angiogenesis and collagen deposition but increases proteolytic activity after MI Angiogenesis and ECM remodelling are critical for post-infarct repair. [22] [23] [24] Immunostaining for CD31 revealed a significantly reduced capillary density in Hspb1 À/À infarcts compared with WT controls 7 days after MI ( Figure 4A , P < 0.01). No significant difference in capillary density was detected between sham-operated mice of the two genotypes (see Supplementary material online, Figure S3 ). ECM formation was also suppressed in Hspb1 À/À hearts after MI, as indicated by decreased collagen I and III expression ( Figure 4B , P < 0.01) and reduced collagen fibre formation ( Figure 4C ) and maturation ( Figure 4D ), compared with WT controls. In striking contrast, Hspb1 À/À hearts showed a marked increase in MMP2 and MMP9 activity compared with WT controls after MI, as indicated by zymography ( Figure 4E ). Hspb1 À/À mice also showed decreased protein expression of a-smooth muscle actin (a marker of fibroblast activation) and N-cadherin (a marker of intercellular integrity) compared with WT controls after MI (see Supplementary material online, Figure S4 ). 
Cardiomyocyte-specific deficiency of HSPB1 aggravates early myocardial inflammation after MI
Inflammation is an early post-MI response, but excessive inflammation impairs post-MI recovery via multiple mechanisms including disruption of ECM and angiogenesis. 23 Neutrophil infiltration was increased after MI, peaking at 24 h and declining thereafter in WT infarcts ( Figure 5A) . However, the MI-induced neutrophil infiltration was markedly higher in Hspb1 À/À infarcts at days 1, 3, and 7 post-MI than in the time-matched WT controls. Notably, by day 7 post-MI, neutrophil infiltration had 24 h after MI (left panel) and primary cardiomyocytes were harvested 6 h after hypoxia (right panel). Total mRNA was extracted for the analysis of Hspb1 mRNA expression levels. Data were expressed as mean ± SD and analysed using unpaired t-test. **P < 0.01, *P < 0.05, n = 6/group. (B) HSPB1 protein expression (immunoblotting). Ventricular tissues were harvested after MI for the indicated times for immunoblotting analysis. Data were expressed as mean ± SD and analysed using one-way ANOVA followed by post hoc test. **P < 0.01, n = 6/group. (C) HSPB1 protein expression (immunostaining). Ventricular tissues at the papillary muscles level were collected after MI for the indicated times. Cryosections were prepared for immunofluorescence staining against HSPB1 (green). Alpha-actinin was used to stain cardiomyocytes (red). Hoechst 33342 reagent was used to counterstain the nuclei (blue). The representative images were from six independent experiments. Scale bars, 1mm for upper panel and 10 lm for down panel. hearts showed significantly more macrophage infiltration than WT controls on day 3 after MI (
Figure 5B).
Consistent with the increased infiltration by neutrophils/macrophages, mRNA levels of inflammatory mediators (Il-1b, Il-8, Il-6, and Icam-1) were increased in Hspb1 À/À mice compared with WT mice after MI ( Figure 5C ). However, these mediators might not be derived fro Immunostaining against HSPB1 (green) was performed. Alpha-actinin was used to stain cardiomyocytes (red). Hoechst 33342 reagent was used to counterstain the nuclei (blue). Note that HSPB1 expression was absent in cardiomyocytes of Hspb1 À/À mice. Scale bars, 10 lm. n = 6/group. (D) KaplanMeier survival curves. Hspb1 À/À and WT mice were subjected to MI insult. Mice survival was recorded within 21 day post-MI. **P < 0.01 analysed by logrank test. n = 22-23 per group. (E and F) Cardiac rupture. Autopsy was performed in MI-induced death of mice. Cardiac rupture was characterized by presence of intrathoracic blood clots (left panel, E) and perforation on the infarcted wall (right panel, E). Note that a significant more incidence of cardiac rupture was detected in Hspb1 À/À mice after MI (F). **P < 0.01 analysed by log-rank test. n = 22-23 per group. TTC staining 24 h post-MI. The red area resembled the vital myocardium and the white area indicated the infarct. Data were expressed as mean ± SD and analysed using unpaired t-test. **P < 0.01, n = 6/group. (B) Cardiac dysfunction and remodelling. Cardiac function and remodelling was examined serially using 2D echocardiography. The representative M-mode images at the papillary muscles were shown in upper panel. Parameters were obtained from M-mode tracings and averaged using three to five cardiac cycles. Data were expressed as mean ± SD and analysed using two-way ANOVA analysis followed by post hoc test. **P < 0.01 and *P < 0.05 vs. the time-matched WT mice, n = 8 for all the groups except for n = 6 in Hspb1 level were collected after MI for 7 days. Cryosections were prepared for immunofluorescence staining against CD31. The representative images were from six independent experiments. Scale bars, 500 lm for the overview images and 100 lm for the infarct, border and remote images. Data were expressed as mean ± SD and analysed using unpaired t-test. **P < 0.01, n = 6/group. (B) Collagen expression. Ventricular tissues were collected 24 h after MI for immunoblotting with the indicated antibodies. Data were expressed as mean ± SD and analysed using two-way ANOVA followed by post hoc test. **P < 0.01, n = 6/group. (C) Collagen fibre formation. Ventricular tissues were collected 3 days after MI for electron microscope analysis. Scale bars, 1 lm, n = 6/group. (D) ECM maturation. Ventricular tissues were collected 7 days after MI. Paraffin-embedded sections were prepared and stained with Sirius red and analysed with polarized light microscopy at a magnification of Â400. n = 6/group. Scale bars, 50 lm. (E) MMPs activation. Ventricular tissues were collected 24 h after MI for zymography analysis. Data were expressed as mean ± SD and analysed using two-way ANOVA followed by post hoc test. **P < 0.01, n = 6-8/group. Cryosections were prepared for immunofluorescence staining against neutrophil (A) or F4/80 (B) (green). Hoechst 33342 reagent was used to counterstain the nuclei (blue). Data were expressed as mean ± SD and analysed using unpaired t-test. *P < 0.05, **P < 0.01, n = 6/group. Scale bars, 50 lm. (C) Cytokines and chemokines in myocardium. Ventricular tissues were collected 24 h post-MI for mRNA analysis. Data were expressed as mean ± SD and analysed using two-way ANOVA followed by post hoc test. **P < 0.01 and *P < 0.05, n = 6-8 per group. (D) Cytokines and chemokines in cardiomyocytes. Primary cardiomyocytes were transfected with Hspb1 siRNA to knock down HSPB1 expression. Cardiomyocytes transfected with scramble RNA served as controls. Following hypoxia for 6 h, cardiomyocytes were harvested for mRNA analysis. Data were expressed as mean ± SD and analysed using unpaired t-tests. **P < 0.01 and *P < 0.05, n = 6/group. cardiomyocytes within Hspb1 À/À hearts, as their expression in primary cardiomyocytes was not affected by Hspb1 knockdown under hypoxic conditions ( Figure 5D and Supplementary material online, Figure S5 ). The expression of Il-10 mRNA was comparable between the two genotypes after MI (see Supplementary material online, Figure S6 ).
HSPB1 deficiency augments chemokine induction in cardiomyocytes after MI
Locally secreted chemokines attract and recruit leucocytes into the myocardium after MI. Although mRNA levels of the chemokines Gro-a, Gro-b, Gro-c, and Ena78 were not significantly different between the two genotypes after MI (see Supplementary material online, Figure S7 ), the expression of the chemokines Ip-10 and Mcp-1 was markedly increased in Hspb1 À/À hearts compared with WT controls ( Figure 5C) . Notably, the increase of Ip-10 and Mcp-1 in Hspb1 À/À infarcts could be attributed to Hspb1 À/À cardiomyocytes, because Hspb1 knockdown markedly increased the expression of these chemokines in primary cardiomyocytes under hypoxia in vitro ( Figure 5D ). The data suggest that HSPB1 acts as a negative regulator of chemokine induction in cardiomyocytes under ischaemic conditions.
3.9 HSPB1 regulates chemokine expression in cardiomyocytes by modulating TLR4/MyD88/NFjB signalling
HSPB1 deficiency activates NFjB
NFjB plays a pivotal role in inducing chemokine expression. 25 We, therefore, evaluated NFjB activation by examining the nuclear translocation of its p65 subunit. No difference in cytosolic NFjB content was observed between the two genotypes after MI ( Figure 6A) . However, by immunoblotting and immunofluorescence, a marked enhancement of MI-induced nuclear translocation of NFjB was detected in Hspb1 À/À hearts compared with WT controls ( Figure 6A and Supplementary material online, Figure S8 ). These increases in NFjB expression and nuclear translocation in Hspb1 À/À MI hearts could be attributed to Hspb1
cardiomyocytes, because knockdown of Hspb1 in primary cardiomyocytes enhanced NFjB expression and nuclear translocation under hypoxic conditions in vitro ( Figure 6B and C).
HSPB1 deficiency enhances TLR4/MyD88/NFjB signalling
Increases in TLR4 and MyD88 expression were observed in Hspb1
hearts compared with WT hearts after MI ( Figure 6D) . IjBa, a downstream target of TLR4/MyD88 that directly prevents NFjB nuclear translocation, was more highly phosphorylated in Hspb1 À/À hearts than in WT controls after MI. Knockdown of Hspb1 in primary cardiomyocytes also increased the expression of Tlr4, Myd88, and Nfjb mRNA under hypoxic conditions in vitro ( Figure 6B and E), suggesting that HSPB1 acts as a negative regulator of TLR4/MyD88/NFjB signalling in cardiomyocytes within MI hearts.
NFjB mediates the enhanced chemokine induction observed in Hspb1 À/À cardiomyocytes
To investigate whether TLR4/MyD88/NFjB signalling mediates the enhanced chemokine induction in Hspb1 À/À cardiomyocytes post-MI, primary cardiomyocytes were treated with PDTC, a widely used NFjB inhibitor. 26, 27 PDTC abolished the enhancement of NFjB nuclear translocation and chemokines (Ip-10 and Mcp-1) induction in Hspb1 knockdown cardiomyocytes under hypoxic conditions ( Figure 7A and Supplementary material online, Figure S9 ). QNZ (EVP4593), another NFjB inhibitor, also abrogated the effect of Hspb1 knockdown on the hypoxia-induced expression of Ip-10 and Mcp-1 in primary cardiomyocytes in vitro (see Supplementary material online, Figure S10A and B). These data suggest that HSPB1 regulates chemokine expression in cardiomyocytes by modulating NFjB signalling under ischaemic conditions.
NFjB mediates the HSPB1 deficiency-induced aggravation of post-MI inflammation
We next examined whether NFjB activation mediates the HSPB1 deficiency-induced aggravation of post-MI inflammation. Notably, PDTC also prevented the enhanced neutrophil recruitment in Hspb1 À/À hearts 24 h after MI ( Figure 7B and Supplementary material online, Figure S11 ).
In the presence of PDTC, Hspb1 À/À hearts showed no difference in neutrophil recruitment from WT controls after MI.
NFjB mediates the HSPB1 deficiency-induced aggravation of cardiac dysfunction after MI
PDTC administration markedly increased EF and FS in both WT and Hspb1 À/À mice 24 h after MI ( Figure 7C ). In the presence of PDTC, no significant difference in EF or FS was observed between Hspb1 À/À and WT mice at 1, 3, 7, 14 and 21 days after MI ( Figure 7C and Supplementary material online, Figure S12 ).
3.12
NFjB mediates the HSPB1 deficiencyinduced exacerbation of ventricular rupture and mortality after MI PDTC administration markedly reduced mortality in both genotypes within 21 days after MI ( Figure 7D ). PDTC also reduced the incidence of cardiac rupture in both genotypes after MI ( Figure 7E ). After treatment with PDTC, Hspb1 À/À mice showed no difference in mortality or cardiac rupture compared with WT mice after MI ( Figure 7D and E).
Discussion
The significant finding of this study is that MI up-regulated HSPB1 expression in cardiomyocytes, while cardiomyocyte-specific deficiency of HSPB1 promoted adverse remodelling following MI, resulting in increased cardiac dysfunction, cardiac rupture, and mortality. This action of cardiomyocyte HSPB1 was due, at least in part, to modulation of the inflammatory response in a NFjB-dependent manner. Our data suggest that cardiomyocyte HSPB1 acts as a negative regulator of inflammation and plays an essential role in repairing tissue damage after MI. Cardiac rupture is a severe and potentially fatal complication of MI. 28 Survival is poor in MI patients who have suffered cardiac rupture, with an in-hospital mortality of 60-90% for LV free wall rupture and 30-50% for ventricular septum rupture. 6 There is no effective therapy for this complication. 6, 28 Based on Becker's classification, acute ruptures occur within 48 h after MI and subacute ruptures occur within 3-10 days after MI in human patients. 6 Although it remains unclear if this classification is also applicable to the mouse model of MI, we did find that deficiency of HSPB1 in cardiomyocytes markedly increased the frequency of MIinduced cardiac rupture, and all the cardiac ruptures occurred within Ventricular tissues were collected 24 h post-MI. Cytosolic and nuclear protein fractions were prepared for immunoblotting against NFjB p65 subunit. Data were expressed as mean ± SD and analysed using two-way ANOVA followed by post hoc test. **P < 0.01, *P < 0.05, n = 6/group. (B) Nfjb p65 mRNA expression in primary cardiomyocytes. Following hypoxia for 6 h, cardiomyocytes were harvested for analysing Nfjb p65 mRNA levels. Data were expressed as mean ± SD and analysed using unpaired t-tests. *P < 0.05, n = 6/group. (C) NFjB p65 nuclear translocation in primary cardiomyocytes. Following hypoxia for 6 h, cardiomyocytes were harvested for immunostaining against NFjB p65 (red). Alpha-actinin was used to stain cardiomyocytes (green). Hoechst 33342 reagent was used to counterstain the nuclei (blue). Scale bars, 10 lm. Data were expressed as mean ± SD and analysed using two-way ANOVA followed by post hoc test. **P < 0.01, n = 6/group. (D) TLR4/MyD88 signalling in myocardium. Ventricular tissues were collected 24 h post-MI for immunoblotting analysis. Data were expressed as mean ± SD and analysed using two-way ANOVA followed by post hoc test. **P < 0.01, *P < 0.05, n = 6/group. (E) TLR4/MyD88 signalling in cardiomyocytes. Following hypoxia for 6 h, cardiomyocytes were harvested for mRNA analysis. Data were expressed as mean ± SD and analysed using unpaired t-test. **P < 0.01, n = 6/group. MI triggers an intense inflammatory response in the myocardium that is characterized by recruitment of neutrophils, macrophages, and monocytes. 6 These leucocytes promote repairment of infarcted hearts by phagocytizing dead tissue and providing growth factors that support angiogenesis and ECM synthesis. 30 However, they also release inflammatory mediators, such as cytokines and reactive oxygen species, which damage nearby cardiomyocytes that survived the ischaemic injury. cytes. Cardiomyocytes were exposed to hypoxia for 6 h in the presence of PDTC. Levels of mRNA were examined. Data were expressed as mean ± SD and analysed using unpaired t-test. n = 6-9/group. (B) Neutrophil infiltration in myocardium. Ventricular tissues at the papillary muscles level were collected at 24 h post-MI in the presence or absence of PDTC. Cryosections were prepared for immunofluorescence staining against neutrophil (green). Hoechst 33342 reagent was used to counterstain the nuclei (blue). Data were expressed as mean ± SD and analysed using two-way ANOVA followed by post hoc test. Scale bars, 50 lm; **P < 0.01 or *P < 0.05, n = 6/group. (C) Cardiac function. Cardiac function was evaluated using echocardiography 24 h post-MI in the presence or absence of PDTC. Data were expressed as mean ± SD and analysed using two-way ANOVA followed by post hoc test. Time stamp and scale bar of M-mode images were shown in the figure. **P < 0.01 or *P < 0.05, n = 8-12/group. (D) Kaplan-Meier survival curves. Mice survival was recorded within 21 day post-MI in the presence or absence of PDTC. **P < 0.01 or *P < 0.05 analysed using log-rank test. n = 19-23/group. N.S., no significance. (E) Cardiac rupture. Autopsy was performed to examine cardiac rupture in MI-induced death of mice in the presence or absence of PDTC. **P < 0.01 or *P < 0.05 analysed using log-rank test. 33, 36 Interestingly, the MI-induced up-regulation of cytokines and genes related to inflammasome signalling (see Supplementary material online, Figure S13 ) was augmented in Hspb1 À/À mice. Taken together, our data suggest a cardiomyocyte-specific role for HSPB1 in the recruitment of leucocytes in MI hearts. These augmented inflammatory responses promote adverse remodelling, impair cardiac function, and increase the risk of cardiac rupture in Hspb1 À/À mice post-MI.
Locally secreted chemokines are critical in attracting and recruiting leucocytes into the myocardium after MI, and NFjB plays a pivotal role in numerous aspects of the inflammatory response, including chemokine expression. 6, 37 Indeed, NFjB inhibition has been shown to decrease the expression of chemokines and cytokines, attenuate cardiac dysfunction and remodelling, decrease the risk of cardiac rupture, and improve the survival of mice post-MI. 11, 38 Interestingly, we observed that Hspb1
hearts showed increased activation of NFjB and increased expression of the chemokines IP-10 and MCP-1 post-MI, and in vitro experiments with primary cardiomyocytes confirmed that these chemokines were attributed to Hspb1 À/À cardiomyocytes. After inhibiting NFjB activity with PDTC, a widely used NFjB inhibitor, 26 ,27 the HSPB1 knockdowninduced increase in chemokine expression in hypoxic cardiomyocytes Figure 8 Scheme represents that Cardiomyocyte-HSPB1 acts as a negatively regulator of NFjB-dependent inflammatory responses and plays essential role in wound healing after MI. In infarcted myocardium, cardiomyocyte TLR4/MyD88 was activated, and IjBa was phosphorylated and degraded, leading to NFjB nuclear translocation to stimulate the expression of inflammatory mediators including chemokines, cellular adhesion molecules, and the genes related to inflammasome activation. The chemokines and adhesion molecules from cardiomyocytes recruit leucocytes into infarcted myocardium to evoke inflammatory injury. HSPB1 was up-regulated in cardiomyocytes in response to MI, while knockout of cardiomyocyte-HSPB1 exaggerated the NFjB-dependent induction of chemokines for further leucocyte recruitment that leading to excessive inflammation, and ultimately caused cardiac rupture and worsened cardiac dysfunction following MI. cardiomyocyte HSPB1 is a negative regulator of NFjB proinflammatory signalling and plays an essential role in wound healing after MI. and the HSPB1 deficiency-induced increase in leucocyte infiltration of infarcted myocardium were abolished. Importantly, PDTC reversed the HSPB1 deficiency-induced aggravation in cardiac dysfunction, cardiac rupture, and mortality following MI. These data suggest that HSPB1 negatively regulates NFjB-mediated chemokine expression in cardiomyocytes in injured myocardium. This pathway is a crucial mechanism through which cardiomyocytes regulate leucocyte trafficking and the subsequent inflammatory response after MI. Activation of NFjB mediates the expression of pro-fibrotic factors such as transforming growth factor-b1 that activate fibroblasts. However, NFjB also drives the expression of chemokines and cytokines that recruit inflammatory cells to damaged cardiac tissue after MI. Some of these chemokines such as IP-10, also possess anti-angiogenic and antifibrotic properties, 4, 7, 9 while other proinflammatory mediators such as IL-1b, can inhibit myofibroblast conversion. 39 Additionally, the recruited inflammatory cells release proteinases that degrade ECM. Thus, optimal tissue repair after MI requires a proper physiological balance between the early inflammatory phase and the subsequent reparative phase. In this study, deficiency of HSPB1 in cardiomyocytes magnified and prolonged inflammation after MI in a NFjB-dependent manner.
In consistence with the observation in male mice, HSPB1 deficiency also exaggerated the MI-induced cardiac injury in female mice (see Supplementary material online, Figure S14) . Moreover, the myocardial ischaemia/reperfusion injury was exaggerated by HSPB1 deficiency (see Supplementary material online, Figure S15 ). However, this study has the following major limitations. First, the mechanism through which HSPB1 regulates NFjB activity in cardiomyocytes has not been clarified. Second, it is not known whether fibroblast activation is involved in the effects of cardiomyocyte HSPB1 during post-MI repair. Finally, the role of HSPB1 in the regulation of angiogenesis in MI hearts remains unknown. These questions should be addressed in future studies.
In summary, we provide novel evidence that HSPB1 in cardiomyocytes is involved in cardiac wound healing post-MI. These actions of HSPB1 in cardiomyocytes are mediated, at least in part, through modulation of NFjB-mediated inflammatory responses (Figure 8) . Targeting HSPB1 expression in cardiomyocytes could be an alternative therapeutic approach for suppressing myocardial inflammation and improving wound healing following MI.
